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ABSTRACT 
Cerium oxide nanoparticles are established scavengers of reactive oxygen and nitrogen species. 
They have many potential biomedical applications that depend on their physicochemical 
properties and mode of preparation. Recent studies have found these nanoparticles possess 
phosphatase mimetic activity. Studying such catalytic activities will qualify their biomedical 
applications and render information on their bioavailability and potential toxicity. 
Two oxidation states of cerium exist in these nanoparticles (3+ or 4+). It is hypothesized that the 
oxidation state of cerium in the nanoparticles determines the amount of adsorbed water on the 
crystal lattices. This in turn governs their activity as phosphatases. Nanoparticles with higher 
levels of cerium in the 4+ state exhibit phosphatase activity while those with higher levels of 
cerium in the 3+ state do not. This phosphatase activity may be controlled with the addition of 
inhibitory anions. It is hypothesized that anions with structures similar to phosphate can inhibit 
phosphatase activity by leading to the production of complexes on the surface of cerium oxide 
nanoparticles. 
Substrates that were used to test this activity include para-nitrophenyl phosphate (pNPP), 4-
methylumbelliferyl phosphate (MUP) and adenosine triphosphate (ATP). To highlight the role of 
adsorbed water, we also performed experiments on pNPP with methanol as a solvent. The 
activity was measured by absorbance (pNPP and ATP) or fluorescence (MUP) and reported as 
nmol of phosphate/min. In some cases this rate was calculated through coupled reactions or by 
measuring the rate of formation of other colored products formed along with the release of 
phosphate such as pNP (para-nitrophenol). 
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The phosphatase activity increased as the amount of adsorbed water increased implying that the 
abundance of adsorbed water makes the surface of 4+ ceria nanoparticles more active. 
Phosphatase activity for all the substrates exhibited Michaelis-Menten kinetics. Although the 
phosphatase activity of these nanoparticles is slow (turnover rate) as compared to real biological 
phosphatases, it can be used as a model catalytic activity to follow other catalytic activities that 
are associated with nanoparticles that have an abundance of cerium in the 4+ state, such as 
catalase activity. These results also provide information on the nature of the active sites involved 
in the catalytic activities associated with these nanoparticles. 
We identified three inhibitors, tungstate, molybdate and arsenate, which decreased the 
phosphatase activity of these nanoparticles in a dose dependent manner. Vmax, Km and Ki values 
were determined by varying substrate concentrations in the presence and absence of inhibitors. A 
partial mixed inhibition model was fit for each of these inhibitors. 
Summary: Phosphatase activity of cerium oxide nanoparticles with higher levels of cerium in the 
4+ oxidation state was used as a model catalytic activity to study the nature of the active sites 
involved in catalysis. The study of inhibitors can reveal more information as to the surface 
binding of substrates in catalysis. 
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INTRODUCTION 
In a report by the US National Science and Technology Council [1] we come across a rather 
simple definition for nanotechnology. 
“The essence of nanotechnology is the ability to work at the molecular level, atom by atom, to 
create large structures with fundamentally new molecular organization. The aim is to exploit 
these properties by gaining control of structures and devices at atomic, molecular, and 
supramolecular levels and to learn to efficiently manufacture and use these devices.” 
Most working definitions of nanotechnology tend to limit nanomaterials as having at least one 
dimension between 1-100nm. The breakdown of larger objects into smaller objects offers two 
distinct advantages. Firstly, the number of such objects increases. If the task at hand requires 
individual objects to perform a certain function then the more of these objects we have, the more 
efficient the functioning of the system will be. Secondly, the surface area of the objects 
increases. If the task at hand requires active contact with objects, then the greater the area 
available for contact, the quicker the process will be. 
These advantages stay intact when we are dealing with biological systems. However, a crucial 
third advantage almost overshadows the first two. Biological environments consist of molecules, 
especially proteins that interact at the nanometer level. This means that the nano-world we have 
stumbled upon in the past few decades has in fact been operational from the very beginning of 
life. If we engineer nanomaterials that fit the dimensions of molecular biology, then we give 
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ourselves a much better chance of interaction with this nano-world. Nanobiotechnology then 
simply refers to the use of nanotechnology to study biological systems. 
Cerium Oxide Nanoparticles 
Cerium oxide is a rare-earth oxide of the lanthanide series. It has an established role in the 
polishing industry but its applications in the biomedical industry have only recently been 
discovered. Cerium oxide nanoparticles exist with two oxidation states for cerium - 3+ and 4+. 
While they have been shown to possess certain enzyme mimetic activities, the exact chemical 
nature of the active sites of these nanoparticles is still unclear. The toxicity of these nanoparticles 
is also under debate. Since the bioavailability, toxico-kinetics and toxico-dynamics of 
nanoparticles are influenced by their physicochemical characteristics [2], we have used the 
phosphatase mimetic activity of cerium oxide nanoparticles as a model catalytic activity. The 
knowledge gained will help qualify their biomedical applications. It will also provide an insight 
on the chemical nature of the active sites involved during catalysis. 
To study the size and oxidation state of the cerium oxide nanoparticles, we have utilized three 
methods – Dynamic Light Scattering (DLS), UV-Visible Spectroscopy and X-Ray Photoelectron 
Spectroscopy (XPS). Very briefly, DLS is a routine technique used to estimate the particle size 
of small particles in solution. It is based on the principle that small particles in solution undergo 
Brownian motion and will scatter light in a manner that fluctuates with time. The scattered light 
can then interfere (either constructively or destructively) and can be used to generate data on the 
movement of particles with respect to time. 
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XPS is a technique that can be used to study the elemental composition of a sample and 
investigate the state of the atoms in that sample. Figure 1 provides a simple schematic for XPS. 
 
Figure 1: A schematic of X-Ray photoelectron spectroscopy 
This image is available in the public domain as a part of Wikimedia Commons: 
http://en.wikipedia.org/wiki/X-ray_photoelectron_spectroscopy#mediaviewer/File:System2.gif 
Samples are irradiated with a beam of X-rays under ultra-high vacuum. The binding energy and 
number of electrons that escape from the surface is measured and displayed as a spectrum. This 
when compared to standard spectra for known elements can help us derive the elemental 
composition of the sample and the state of the atoms that are present in the sample. 
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Major Aims of this Project 
The first aim of this project was to investigate the mechanism of phosphatase activity of cerium 
oxide nanoparticles. A suitable mechanism was proposed based on similarity to established 
models of enzyme kinetics. Several preparations of cerium oxide nanoparticles were tested to 
correlate material properties to catalytic efficiency. 
The second aim of this project was to highlight the role of water in the hydrolytic chemistry 
involved during removal of phosphate groups from donor substrates. A clear relationship 
between the amount of water required for catalysis and the rate of phosphatase activity was 
established. 
The final aim of this project was to establish the role of inhibitory anions in controlling the 
phosphatase activity of cerium oxide nanoparticles. Dose dependent in vitro assays were 
conducted to establish the nature of these inhibitors. Multiple substrates were used to rule out 
potential artifacts that might occur in these chemical reactions. 
Phosphatase Activity 
Throughout the course of this project we used both artificial substrates such as para-nitrophenyl 
phosphate (pNPP) and 4-methylumbelliferyl phosphate (MUP) as well as bio-relevant substrates 
(ATP) to measure the phosphatase activity of cerium oxide nanoparticles. Reasons for choosing 
this activity include the simplicity of measurement and the fact that it can be used as a model for 
other key catalytic activities of cerium oxide nanoparticles. 
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Enzyme Inhibition  
Models for enzyme inhibition are now well established and software can use standard models to 
generate kinetic parameters for given experiments. Figure 2 provides a simple schematic for the 
different routes in a single substrate reaction. 
 
Figure 2: Different routes in enzyme inhibition 
E is used to denote the Enzyme. The symbols S, P and I are used for the Substrate, Product and 
Inhibitor respectively. K with different subscripts is used to denote the dissociation constant for 
each reaction. The symbols α and β represent constants that are used to classify the type of the 
inhibition. While α helps distinguish models based on type of complex formed, β helps 
distinguish between full and partial inhibition of the reaction. Table 1 summarizes the different 
types of enzyme inhibition and the routes followed. 
Table 1: Different types of enzyme inhibition 
TYPE OF INHIBITION PATH FOLLOWED 
Competitive I binds to only E 
Mixed I binds to both E and ES 
Non-Competitive (Special Mixed) I binds to both E and ES with equal affinity 
Uncompetitive I binds to only ES 
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The Michaelis-Menten model for enzyme kinetics is a common model for most basic enzymatic 
reactions. The phosphatase activity of cerium oxide nanoparticles also follows Michaelis-Menten 
kinetics. The model is described by the following equation. 
   
         
      
 (1) 
Where v is the initial rate of the reaction, Vmax is the maximum rate of the reaction, Km is the 
Michaelis-Menten constant and S is the Substrate. Since this does not produce a linear plot, the 
equation is often modified to the double reciprocal plot or Lineweaver-Burk equation. The 
equation is as follows. 
 
 
 
  
         
 
 
    
 (2) 
This equation is linear and thus makes calculation of kinetic parameters easier. One example of a 
model for enzyme inhibition is partial mixed inhibition. This model encompasses all possible 
routes that the reaction can follow and thus Figure 2 is an apt schematic for it. The rate of 
reaction for this model is given by the following equation. 
   
         (    )
  (   
   
  
)    (  
   
      
)
 (3) 
Since β involves a second route for the product to form it makes sense that it is in the numerator. 
The constant α on the other hand, is involved in the formation of EIS complex and thus should be 
part of the denominator. It is quite easy to note that equation 3 is derived from equation 1. 
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Phosphatases in Biology 
Simply put, a phosphatase is an enzyme that removes a phosphate group from a donor substrate 
with the help of water. This means that they act in direct opposition to kinases and 
phosphorylases. 
Alkaline phosphatases are the most common type in biological environments. Kinases along with 
phosphatases are integral to many signal transduction pathways. This is because proteins are 
activated and deactivated by the addition and removal of phosphate groups. Additionally 
phosphatases such as Calf Intestinal Phosphatase (CIP) are useful in removal of phosphorylated 
ends of DNA and RNA. This allows end-labeling of probes. One of the experiments in this 
project involved comparing the phosphatase activity of CIP with that of cerium oxide 
nanoparticles. 
Addition or removal of phosphate groups is also vital in energy maintenance because it pertains 
to the energy storage molecule, ATP. ATP cleaves into ADP and inorganic phosphate and 
releases energy while doing so. This energy is then used to carry out all kinds of cellular 
functions. Thus there is a need to maintain a fine balance for ATP levels in order to control 
metabolic activities. Nanoparticles that can alter ATP levels may disrupt this fine balance and 
hence be toxic. Studying the ATPase activity of cerium oxide nanoparticles will provide us with 
information on their toxicity. 
  
8 
 
LITERATURE REVIEW 
This chapter begins with a brief overview of the structural properties of cerium oxide and their 
known catalytic activities. It then continues to the applications of cerium oxide nanoparticles in 
the biomedical industry. Finally a few industrial applications are discussed. 
Structural Properties of Cerium Oxide Nanoparticles 
Cerium exists in two oxidation states in cerium oxide nanoparticles – 3+ and 4+. The most 
common deviations from the regular structure of the stoichiometric surface (found in bulk 
cerium oxide) are surface oxygen vacancies (due to an increased amount of 3+), water adsorbed 
on top of cerium ions and hydroxide substituting surface oxygen [3]. Dynamic scanning force 
microscopy has been used to study the adsorption of water molecules on a stoichiometric CeO2 
(111) surface at room temperature. It is suggested that water molecules localize exclusively on 
this type of site that is associated with the cerium-ion sub-lattice and stick to the surface with an 
estimated surface diffusion barrier of 1eV [4]. 
A recent report suggests that cellular interactions and toxicity of these nanoparticles depend on 
their physicochemical properties and surface modifications[5]. The presence of Ce
3+
 implies the 
defect structure Ce02-x for ceria nanoparticles due to oxygen vacancies. Figure 3 shows a 3D 
model of the cerium oxide lattice. Cerium atoms are shown in red while oxygen atoms are off-
white. Oxygen vacancies are introduced during the synthesis of cerium oxide nanoparticles and 
can be thought as one of the off-white atoms popping out from the lattice. This lends an overall 
CeO2-x structure to the lattice. The transformation of ceria 4+ to 3+ plays a vital role in the 
catalytic properties of ceria [6]. 
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Figure 3: Overall Ce02-x structure of lattice 
This image is available in the public domain as a part of Wikimedia  
Commons: http://en.wikipedia.org/wiki/File:Ceria-3D-ionic.png 
The surface reactivity of cerium oxide nanoparticles is critically dependent upon the nature of the 
environment in which they reside. Simulations predict higher activities of ceria nanoparticles, 
towards oxygen release, when immersed in water. Atomistic simulations though, inherently do 
not account for the biological environment surrounding these nanoparticles. Molecular 
simulations, on the other hand, are more realistic in predicting their surrounding environment. 
Figure 4 [7] shows surface rendered models of cerium oxide nanoparticles crystallized in water. 
The surface is colored according to calculated electrostatic potential revealing reactive (red) 
compared to unreactive (blue) regions on the nanoparticle. 4(b) is as 4(a) but after removal of 
water and system minimization. 
 
Figure 4: Surface rendered models of cerium oxide nanoparticles 
Reproduced from [7] with permission of The Royal Society of Chemistry. 
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Nanoparticles with high 3+/4+ ratio show minimal phosphatase activity while those with a low 
3+/4+ ratio show significant phosphatase activity. Removal of phosphate groups from both 
artificial substrates such as pNPP or MUP, and bio-relevant substrates such as ATP, is thought to 
involve hydrolytic chemistry. 
ROS/RNS Scavenging and Enzyme Mimetic Activities 
Cerium oxide nanoparticles have been shown to scavenge nitric oxide [8] and superoxide 
radicals [9]. Nanoparticles with ceria predominantly in the 4+ state are better at scavenging nitric 
oxide radicals while those with a 3+ state predominance can scavenge superoxide radicals more 
efficiently [8]. A review article in 2010 [10] expounds the role of cerium oxide nanoparticles in 
effectively protecting mammalian cells. They have also been shown to significantly alter the rate 
of decay of peroxynitrite [11] as well as exhibit catalase mimetic activity in the 4+ state [12]. 
Some studies have indicated a more toxic nature, i.e., cerium oxide nanoparticles can generate 
reactive oxygen species depending on certain crucial factors such as buffer anions [13]. The 
report defines the effects of different buffer anions by using Tris-HCl, sulfate, and phosphate 
buffer solutions and illustrates their DNA protective effect. The results indicate that cerium oxide 
nanoparticles can protect DNA from damage in Tris-HCl and sulfate systems, but not in 
phosphate buffer solution systems. Cerium phosphate formed on the surface of the nanoparticles, 
interferes with the redox cycling between Ce
3+
 and Ce
4+
. 
Table 2 is drawn from information reported in two studies [5, 11] and shows the various bio-
catalytic properties of Ce
3+
 and Ce
4+
. 
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Table 2: Bio-catalytic activities of cerium oxide nanoparticles 
CATALYTIC ACTIVITY Ce
3+
 Ce
4+
 
Phosphatase
a
 No Yes 
∙NO scavengera No Yes 
Catalase mimetic
a
 No Yes 
SOD mimetic
a
 Yes No 
Peroxynitrite scavenger
b
 Yes Yes 
Superscript ‘a’ represents data taken from [5] while ‘b’ represents data taken from [11]. 
A report in 2011 [14] suggests that cerium oxide nanoparticles are resistant to broad changes in 
pH and are unaltered by incubation in cell culture medium. However, phosphate anions 
significantly alter their characteristics and shift the catalytic behavior when incubated in 
phosphate buffer. Therefore it is speculated that the local concentration of phosphate anions in 
cells can greatly affect the catalytic properties of nanoparticles. 
Other Biomedical Applications 
Commercial availability of cerium oxide nanoparticles makes it extremely likely that they will be 
introduced into the environment. This validates the need to gather knowledge of their fate, 
transport and bioavailability in natural aquatic systems [2]. Characterizing the environmental 
transport and quantifying the risk of nanoparticles involves understanding the aggregation of 
nanoparticles [15]. 
PEGylation of the surface provides stealth characteristics to nanoparticles so that they are not 
identified as foreign materials by the human body [16]. Cerium oxide nanoparticles have been 
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shown to trigger angiogenesis by modulating the intracellular oxygen environment and 
stabilizing hypoxia inducing factor 1alpha (HIF-1α) endogenously [17]. In addition, 
nanocomposite scaffolds of bioactive glass foams containing tailor made nanoceria additives 
have been shown to enhance the production of collagen by HMSCs [18]. 
Industrial Applications 
Industrial applications of cerium oxide take advantage of cerium’s high thermodynamic affinity 
for oxygen and sulfur and the unique absorption/excitation energy bands associated with its 
electronic structure [19]. Most activities of cerium oxide nanoparticles work on the shuttling 
between cerium in 3+ and 4+ states. 
Slurries of cerium oxide have traditionally been used in glass polishing. Cerium oxide 
nanoparticles are currently also used as an abrasive for chemical-mechanical planarization 
(CMP) of integrated circuits [20]. CMP is a technique used to smoothen out surfaces using 
chemical and mechanical forces. In nanoelectronics, it is used to connect individual transistors 
on a chip. This is incredibly useful for mass-manufacturing of chips for nanoelectronics as it gets 
rid of a majority of polishing defects. 
The slurry for CMP usually contains particle-based abrasives. Spherical nanoparticles are ideal 
polishing agents because they can act like ball bearings and reduce the scratching of surfaces 
[20]. The exact polishing mechanism using ceria based slurries remains unclear but 
Suphantharida et al. [21] implicate that the adsorption of silicate ions on ceria may be necessary 
for the removal mechanism of silicon-based materials in the CMP technique. 
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Cerium oxide nanoparticles are also used in water-gas shift catalysis, combustion catalysis, 
oxygen ion conductors, solid oxide fuel cells [22] and in electrochromic thin films [23]. 
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METHODOLOGY 
This chapter starts off with a description of the method used to prepare cerium oxide 
nanoparticles. It goes on to describe the methods used to characterize the nanoparticles. 
Subsequently, a detailed methodology for the various assays to check phosphatase activity is 
provided. The assays are described in an order that matches the aims described in the 
introduction. Finally the methodology adopted for comparing phosphatase activity of cerium 
oxide nanoparticles to that of CIP is described. 
Preparation of Cerium Oxide Nanoparticles 
This project utilized two preparations of cerium oxide nanoparticles – one with a high Ce3+/Ce4+ 
ratio and one with a low Ce
3+
/Ce
4+
 ratio. All nanoparticles that were used in this project were 
prepared by the same wet chemical method described by Das et al. [17]. The precursor used was 
cerium nitrate hexahydrate (99.999% pure from Sigma Aldrich, St. Louis, MO). The precursor 
was dissolved in distilled water and stoichiometric amounts of H202 (for high Ce
3+
/Ce
4+
 ratio) or 
NH4OH (for low Ce
3+
/Ce
4+ 
ratio) were added. The resulting solutions for each case were mixed 
thoroughly. The NH4OH solution was washed four times with double distilled water and 
resuspended in the same volume of water. The pH of these solutions was adjusted to 3 to 
maintain stable suspensions. Surface modified cerium oxide nanoparticles were prepared using 
hexamethylenetetramine (HMT) [24]. This sample was called HMT-ceria. For convenience, 
nanoparticle solutions with a high Ce
3+
/Ce
4+  
ratio are labeled as 3+ while those with a low 
Ce
3+
/Ce
4+ 
ratio are labeled as 4+. This does not imply the lack of one state in a preparation. 
Instead it seeks to identify the dominant state in each preparation. It is important to note that the 
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precursor was originally at 5mM and so the resulting solution’s cerium concentration was also 
5mM. This does not equate to the concentration of cerium oxide nanoparticles. There are 
thousands of cerium atoms in a nanoparticle and the actual concentration of the active sites at the 
surface of these nanoparticles is unclear. The subsequent sections mention values for the 
nanoparticle concentration. These values actually refer to the cerium concentration in these 
nanoparticles. 
Characterization of Cerium Oxide Nanoparticles 
The consistency between different batches of nanoparticles for size was confirmed by DLS 
measurements. The Zetasizer Nano ZS (Malvern Instruments, Worcestershire, UK) was used to 
measure the size of different batches of 4+ nanoparticles at [Ce
4+
] = 250µM. Size was calculated 
before and after 5 minutes of ultrasonication of the samples in 1 ml cuvettes. 
The consistency in Ce
3+
/Ce
4+
 ratio was confirmed by observing the similarity in the UV-Visible 
spectra of different batches. An Agilent 8453 (HP) UV-Vis Spectrophotometer (Agilent 
Technologies, Santa Clara, CA, USA) was used to measure the spectra of 4+ and 3+ 
nanoparticles at 125µM. 50µl of sample was placed in a quartz spectrophotometer cell (Starna 
Cell, Inc., Atascadero, CA, USA) and both UV and visible lamps were switched on to observe 
the spectra from 200-900nm. 
The state of cerium oxide nanoparticles with and without inhibitory anions (tungstate, molybdate 
and arsenate) was observed by a PE-PHI-5400 X-Ray Photoelectron Spectrometer (Physical 
Electronics, Chanhassen, MN, USA). 15µl each of 5mM nanoparticle solution and 5mM 
inhibitor solution were mixed and applied to silicon wafers. The wafers were allowed to dry and 
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the process was repeated 6 times till a distinct film of the sample was visible on the wafers. 
Samples were then loaded with the assistance of the staff at the Material Characterization 
Facility AMPAC of the University of Central Florida. Samples were aligned to maximize signal 
and then a survey was performed to check the contents of the sample. Subsequently, XPS spectra 
for the elements in question were obtained for at least 3 cycles with at least 5 sweeps. Spectra for 
cerium 3d orbitals were generated and the Ce
3+ 
concentration was reported. 
Phosphatase Activity of Cerium Oxide Nanoparticles 
The phosphatase activity of cerium oxide nanoparticles was detected using four different assays 
that used different phosphate donors as substrates. Methods of detection included absorbance and 
fluorescence. The substrates used were - pNPP and MUP (artificial) and ATP (bio-relevant). 
Mechanism of Phosphatase Activity 
The assays with artificial substrates were used to understand the mechanism of the phosphatase 
activity of cerium oxide nanoparticles. Initially various compounds were screened to detect 
phosphatase activity in the pNPP assay. Subsequently the activity of 4+ and 3+ cerium oxide 
nanoparticles was compared. This was followed by a series of experiments to track saturation of 
phosphatase activity and replenish substrate at the point of saturation. SigmaPlot® 12.5 (Systat 
Software, Inc., Point Richmond, CA, USA) was used to generate Michaelis-Menten curves and 
Lineweaver-Burk plots and it provided values for Vmax and Km. 
pNPP Assay 
The phosphatase mimetic ability of CeO2 nanoparticles was assayed by the hydrolysis of para-
nitrophenyl phosphate (New England BioLabs Inc., Ipswich, MA, USA) into para-nitrophenol, 
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which turns into its conjugate base, para-nitrophenolate. All tests were conducted in 96 well 
plates and the well volume was maintained at 200µl by adding appropriate amounts of water. 
HEPES at a pH of 7 and a concentration of 50mM was used as a buffer for the reaction. The 
reaction was followed by measuring the absorbance at 405nm (for para-nitrophenolate) using a 
Spectramax 190 UV-Visible spectrophotometer (Molecular Devices, Sunnyvale, CA, USA). 
SigmaPlot® 12.5 was used to draw normalized absorbance vs time graphs. 
Screening of Various Catalysts 
The substrates used were yttrium oxide, indium tin oxide, cerium oxide powder, HMT-nanoceria, 
cerium oxide – yttria doped, water based 4+ nanoceria and sodium hydroxide. The concentration 
of pNPP was maintained at 1.2mM. The reaction was followed by measuring the absorbance 
every minute for 20 minutes. The same procedure was followed for 4+ and 3+ cerium oxide 
nanoparticles at 100µM to compare their phosphatase activity. 
Saturating the Catalyst and Replenishing Substrate 
A similar procedure to the one just described was used to observe the time taken for the reaction 
to saturate using 4+ cerium oxide nanoparticles at 100µM. Two pNPP concentrations were tested 
– 1.2mM and 9.6mM. The reaction was followed for 60 minutes. Subsequently an experiment 
was conducted to replenish 1.2mM pNPP at the end of 60 minutes with the nanoparticle 
concentration being 200µM. 
Kinetics of Phosphatase Activity 
The 4+ nanoparticle concentration was fixed at 200µM. Different concentrations of pNPP were 
used – 0.3, 0.6, 1.2, 2.4, and 4.8mM. The experiment was conducted 3 times with triplicates in a 
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96 well-plate. The initial rate of the reaction from minute 1 to 6 was calculated by using the 
change in absorbance (Δabs/min). Average rates from each triplicate set were then used to 
calculate the initial rate of pNP formed in nmol/min using the molar extinction coefficient for 
pNPP (=18.5mM
-1
cm
-1
). The rate of phosphate formed was the same as that of pNP because of 
stoichiometry. Vmax and Km values were generated by SigmaPlot® 12.5 along with a Michaelis-
Menten curve and a Lineweaver-Burk plot. 
MUP Assay 
To corroborate evidence, phosphatase activity of cerium oxide nanoparticles was also detected 
by fluorescence in the MUP assay. A 10mM stock of 4-Methylumbelliferyl phosphate 
(Molecular Probes Inc., Eugene, OR, USA) was made in HEPES (at pH 7). The reaction 
involved exciting 1mM of MUP at 360nm and detecting the fluorogenic product, 4-
methylumbelliferone at 449nm. Fluorescence was detected by Varian Cary Eclipse Fluorescence 
Spectrophotometer (Agilent Technologies, Santa Clara, CA, USA) once every minute. The assay 
was performed in white round-bottomed 96 well-plates. The reaction volume was maintained at 
200µl by adding water. HEPES was maintained at a concentration of 25mM and cerium oxide 
nanoparticles were at 200µM. The rate of phosphate formation was calculated in Δintensity/min.  
The phosphatase activity of 4+ and 3+ nanoparticles was compared (followed for 20 minutes) 
and the time taken for the assay to saturate was observed (followed for 2 hours). 
Malachite Green Assay 
The phosphatase activity was further confirmed by using a bio-relevant substrate. The 
phosphatase activity of CeO2 nanoparticles was assayed by the hydrolysis of ATP (Sigma 
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Aldrich, St. Louis, MO, USA) using the Malachite Green phosphate detection kit (RnD Systems, 
Minneapolis, MN, USA). HEPES at a pH of 7 and a concentration of 50mM was used as a buffer 
in the reaction. All tests were conducted in 96 well plates and water was used to bring the 
reaction volume to 100µl. The nanoparticle concentration was 200µM while the concentration of 
ATP was varied between 0 and 200µM. Volumes of ATP were added at different intervals for a 
30 minute period to simulate a kinetically followed reaction. 20µl each of Reagent A, with 10 
minutes of incubation, and Reagent B, with 20 minutes of incubation, were used as reaction 
stopping agents and they produced the chromogenic product to be measured at 620nm. End-point 
absorbance was measured at 620nm using a Spectramax 190 UV-visible spectrophotometer. A 
phosphate standard from the kit was used to enable the establishment of standard curve that 
related the absorbance to nmol of phosphate per well. 
EnzChek® Phosphate Assay  
A second assay was used to confirm activity for a bio-relevant substrate. The phosphatase 
mimetic activity of CeO2 nanoparticles was assayed by the hydrolysis of ATP using the 
EnzChek® Phosphate Assay Kit (Molecular Probes Inc., Eugene, OR, USA). In the presence of 
Pi, the substrate 2-amino-6-mercapto-7-methyl purine riboside (MESG) is enzymatically 
converted by purine nucleoside phosphorylase (PNP) into ribose 1-phosphate and 2-amino-6-
mercapto-7-methylpurine. This conversion can be followed at 360nm. UV transparent 96 well-
plates were used. The concentration of nanoparticles was 200µM while that of ATP was 100µM. 
The reaction was followed (after 10 minutes of incubation) for 30 minutes at one minute 
intervals using a Spectramax 190 UV-visible spectrophotometer. Phosphate standard from the kit 
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was used to derive a standard curve that related the absorbance to nmol of phosphate per well. 
SigmaPlot® 12.5 was used to draw a graph of phosphate formed (nmol/well) vs time. 
Role of Water in Phosphatase Activity 
The role of water in the phosphatase activity of cerium oxide nanoparticles was studied by 
replacing water with methanol in steps of 10% of the reaction volume (20-120µl). Experiments 
were conducted only for the artificial substrates (pNPP and MUP). 
The general strategy for these assays was the same as described above. Nanoparticle 
concentrations were kept at 200µM. The actual concentration of water in the reaction was 
calculated by using percentages of 55.55M and working backwards serially. For the pNPP assay, 
the initial rate of pNP formed was calculated in nmol/min. The concentration of pNPP was 
1.2mM. For the MUP assay, rates were left in Δintensity/min. The concentration of MUP was 
500µM. SigmaPlot® 12.5 was used for both assays to draw a graph of rate of reaction in 
nmol/min or Δintensity/min vs water concentration (M). 
Inhibition of Phosphatase Activity 
Preliminary experiments were conducted with sodium salts of sulfate, selenate, tungstate, 
arsenate and molybdate. Kinetic parameters were found for the anions that were able to inhibit 
phosphatase activity (tungstate, molybdate and arsenate). 
pNPP Assay 
Concentration of the inhibitory salts used were [I] = 0.2, 0.5 and 1mM. After choosing the anions 
that inhibited phosphatase activity (tungstate, molybdate and arsenate), kinetic studies were 
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performed over [pNPP] = 0.3, 0.6, 1.2, 2.4 and 4.8mM and [I] = 0, 0.15, 0.3 and 1.8mM. Rates 
were calculated in nmol/min using molar extinction coefficient for pNPP (=18.5mM
-1
cm
-1
). The 
experiments were conducted 3 times with triplicates in a 96 well-plate. The Enzyme Kinetics 
wizard of SigmaPlot® 12.5 was used to test different models of enzyme inhibition. Models were 
fit to the data and ranked according to their R
2
 values. The Akaike Information Criterion (AIC) is 
used to compare non-nested models of enzyme kinetics. It deals with the trade-off between the 
goodness of fit of the model and the complexity of the model. AICc refers to the same criterion 
with a correction for finite sample sizes. This means that there is a greater penalty for extra 
parameters. Secondary consideration was given to their AICc values while choosing a model for 
inhibition. Michaelis-Menten curves and Lineweaver-Burk plots were generated for all the 
models. Values of Vmax, Km, Ki, α and β were generated for the chosen model. 
MUP Assay 
To corroborate evidence from pNPP assays, inhibition of phosphatase activity of cerium oxide 
nanoparticles was also detected by fluorescence in the MUP assay. The reaction involved 
exciting 0.5mM of MUP at 360nm and detecting the fluorogenic product, 4-methylumbelliferone 
at 449nm. Inhibitor concentrations used were 25, 50, 100 and 200µM. Fluorescence was detected 
in the same manner as described previously. The reaction volume was maintained at 200µl by 
adding water. HEPES was maintained at a concentration of 25mM and cerium oxide 
nanoparticles were at 200µM. 
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Malachite Green Assay 
The inhibition of phosphatase activity was further confirmed by using a bio-relevant substrate. 
The nanoparticle concentration was maintained at 200µM while the concentration of ATP was 
varied between 0 and 200µM. The inhibitor concentration was also varied between 0 and 
200µM. The rest of the experiment was conducted as described above. 
EnzChek® Phosphate Assay  
A second assay was used to confirm activity for a bio-relevant substrate. The concentration of 
nanoparticles was maintained at 200µM while that of ATP was 50µM. Inhibitor concentrations 
used were 100 and 200µM. The rest of the experiment was conducted as described above. 
Phosphatase Activity of Biological Phosphatase 
Alkaline Phosphatase - Calf Intestinal (New England BioLabs® Inc., Ipswich, MA, USA) was 
used as a comparison for the phosphatase activity of cerium oxide nanoparticles. Experiments 
were conducted with pNPP at 1.2mM and in CutSmart™ buffer at 37ºC. The reaction was 
followed for 7 minutes at 405nm using the same technique as described previously. The enzyme 
formulation had a concentration of 3.33mg/ml (10000U/ml with specific activity of 3000U/mg). 
This was treated as 47.83µM as the theoretical molecular weight of the protein was 69kDa. By 
trial and error a value for enzyme volume was found such that change in absorbance with time is 
roughly the same for both enzyme and nanoparticles. This value represented a final enzyme 
concentration of about 570nM in the 200µl reaction well. 
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Experiments were conducted in triplicate with and without 0.3mM of inhibitors (tungstate, 
molybdate and arsenate). As a comparison, 4+ cerium oxide nanoparticles at 200µM were used 
in the same environment to demonstrate their phosphatase activity.  
24 
 
RESULTS AND DISCUSSION 
This chapter discusses the results for the various experiments described in the methodology 
section. The order in which these results are described matches the aims of this project. Each 
figure is followed by its discussion. 
Size of 4+ Nanoparticles 
The size of 4+ nanoparticles used was confirmed by DLS measurements before and after 
ultrasonication. Different batches of 4+ and 3+ nanoparticles were tested to examine consistency 
in their spectra. Figure 5 and 6 show the size distribution of 4+ nanoparticles before and after 
ultrasonication respectively. 
 
Figure 5: 4+ nanoparticles are between 10-20nm in size before ultrasonication 
Size was measured by DLS before ultrasonication. [Ce
4+
] = 250µM. Each color represents a 
replicate of the same sample. Size was measured 11 times for each replicate. 
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Figure 6: 4+ nanoparticles are about 10nm in size after ultrasonication 
Similar methodology as that for Figure 5 was adopted. Size was measured by DLS after 5 
minutes of ultrasonication. [Ce
4+
] = 250µM. 
The nanoparticle size did not change significantly with ultrasonication. This suggests that that 
there is no significant aggregation of nanoparticles over time. The average size seemed to peak at 
around 10nm which is well within the nano-world range of 1-100nm and thus will provide all the 
benefits of smaller size. A consistent size also ensures consistent activity for each batch of 
nanoparticles. 
UV-Visible Spectra of Nanoparticles 
Figure 7 shows the UV-Visible spectra of cerium oxide nanoparticles. Table 3 shows the 
resultant maxima and minima for different batches of nanoparticles used. 
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Figure 7: Different batches of cerium oxide nanoparticles have consistent UV-Visible spectra 
UV-Visible spectra for different batches of 4+ and 3+ nanoparticles (both at 125µM) are shown 
from 200-400nm. 
Several batches of cerium oxide nanoparticles had largely consistent spectra. This was an 
important result because it confirmed that all the experiments conducted in this project used 
fairly uniform batches of cerium oxide nanoparticles. The spectra of 4+ nanoparticles had a 
maximum at around 290nm and a minimum at around 242nm. The spectra for 3+ nanoparticles 
on the other hand had two maxima at around 253nm and 298nm and two minima at around 
281nm and 247nm. The consistency in the absorbance of different batches suggests that their 
3+ CNP batches 
4+ CNP batches 
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concentrations were also fairly uniform. This suggests that 5mM of cerium in the solutions of 
nanoparticles led to a consistent nanoparticle concentration for all batches. 
Table 3: Consistent maxima and minima for different batches of cerium oxide nanoparticles 
Batch Maxima(nm) Absorbance(AU) Minima(nm) Absorbance(AU) 
4+(6/18/13) 290.0 0.72511 242.0 0.65304 
4+(12/19/13) 288.0 0.69664 242.0 0.62575 
4+(4/2/14) 288.0 0.70123 --- ----- 
4+ sonicated(6/18/13) 289.0 0.76484 242.0 0.67697 
4+ sonicated(12/19/13) 288.0 0.71349 242.0 0.63717 
4+ sonicated(4/2/14) 289.0 0.69630 245.0 0.62834 
3+ 
253.0 
298.0 
0.17581 
0.04949 
281.0 
247.0 
0.04508 
0.16007 
3+ sonicated 
253.0 
296.0 
0.22240 
0.09935 
281.0 
247.0 
0.09337 
0.20712 
Dates on which 4+ nanoparticle samples were received are mentioned in brackets. 
Role of Water in Phosphatase Activity 
The role of water in the cleavage of phosphate from donors for the phosphatase activity of 4+ 
cerium oxide nanoparticles was demonstrated. Figure 8 shows the increase in rate of the reaction 
with the addition of water instead of methanol in the pNPP Assay. 
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Figure 8: Phosphatase mimetic activity increases with addition of water in the pNPP assay 
Water was replaced by methanol in steps of 10% of the reaction volume (20-120µl). The actual 
concentration of water (M) in the reaction was calculated by using percentages of 55.55M and 
working backwards serially. [pNPP] =1.2mM and [Ce
4+
] = 200µM. 
The figure clearly shows that the phosphatase mimetic activity increases linearly with the 
addition of water to the reaction volume. This strongly suggests that the phosphatase activity is 
due to the hydrolytic cleavage of the phosphate group from the donor substrate. Figure 9 shows a 
similar result in the MUP assay. This time the rate is left in terms of Δintensity/min. The sudden 
spike at the last point can be attributed to the fact that the Emmax of the samples with methanol 
will be slightly different from the sample with no methanol (or only water). The curve is linear 
for the region that has methanol and this corroborates the results from the pNPP assay. 
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Figure 9: Phosphatase mimetic activity increases with addition of water in the MUP assay 
Similar methodology to that of Figure 8 was adopted. [MUP] =500µM and [Ce
4+
] = 200µM. 
To summarize, the results clearly point at hydrolytic chemistry being involved in the cleavage of 
phosphate from donor substrates. The adsorption of water on the surface of 4+ cerium oxide 
nanoparticles makes them more active for phosphatase mimetic activity. 
Mechanism of Phosphatase Activity 
The results for the experiments conducted to confirm phosphatase activity of cerium oxide 
nanoparticles are discussed below. Figure 10 shows the phosphatase activity of different 
catalysts in the pNPP assay. As can be seen from the figure water based 4+ cerium oxide 
nanoparticles exhibit the highest level of phosphatase activity. HMT-ceria showed some activity 
and this is useful when considered with the fact that HMT-ceria has a better uptake by cells than 
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water based cerium oxide nanoparticles [5]. All other catalysts, including doped forms of cerium 
oxide showed close to no phosphatase activity. 
 
Figure 10: Water based nanoceria exhibits higher phosphatase activity than other forms of ceria 
Various metal oxides and doped forms of ceria were tested for phosphatase activity. [pNPP] = 
1.2mM and [Ce
4+
] = 100µM. 
Figure 11 shows a comparison between the phosphatase activities of 4+ and 3+ cerium oxide 
nanoparticles in the pNPP assay. Clearly the 4+ cerium oxide nanoparticles possess phosphatase 
activity while the 3+ cerium oxide nanoparticles do not. The minimal activity shown by 3+ 
nanoparticles saturates within minutes. 
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Figure 11: 4+ nanoparticles exhibit phosphatase mimetic activity while 3+ nanoparticles do not 
Similar methodology to that of Figure 10 was adopted. [pNPP] = 1.2mM and [Ce
4+
] = 100µM. 
Figure 12 shows the saturation of phosphatase activity of 4+ nanoparticles in the pNPP assay. 
The figure clearly shows that rate of reaction remains almost linear over long periods of time. At 
the end of 60 minutes the absorbance curve for 1.2mM pNPP begins flattening but the 9.6mM 
curve remains on its increasing course. This result illustrates that cerium oxide nanoparticles can 
remain phosphatases over large periods of time given that there is enough substrate to carry the 
reaction forward. 
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Figure 12: Phosphatase activity of nanoceria stays linear over long periods of time 
Similar methodology to that of Figure 10 was adopted. [pNPP] = 1.2mM and 9.6mM and [Ce
4+
] 
= 200µM. The activity just begins to saturate at 60 minutes for the lower concentration of pNPP. 
Figure 13 shows a sudden spike in phosphatase activity after replenishing substrate (1.2mM 
pNPP) at the end of 60 minutes. The figure clearly shows that the phosphatase activity was 
saturated at the end of 60 minutes and spiked again with the addition of fresh substrate. This 
strengthens the claim that the 4+ nanoparticles remain as such at the end of the reaction and can 
be reused as phosphatases. 
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Figure 13: Phosphatase activity is revived after replenishment of substrate 
Similar methodology to that of Figure 12 was adopted. [pNPP] = 1.2mM and [Ce
4+
] = 200µM. 
Reaction mix was replenished with 1.2mM pNPP at the end of 60 minutes. This caused a revival 
of phosphatase activity. 
Figure 14 shows the Michaelis-Menten curve for kinetics of phosphatase activity in the pNPP 
assay without any inhibitors. The Vmax and Km values were 0.4371nmol/min and 0.7373mM 
respectively. 
The figure clearly shows that cerium oxide nanoparticles follow a Michaelis-Menten profile for 
phosphatase activity. The Y axis is reported as the initial rate of pNP formed and is equal to the 
rate of phosphate formed. 
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Figure 14: Phosphatase activity of 4+ nanoparticles follows Michaelis-Menten kinetics 
Different concentrations of pNPP were used – 0.3, 0.6, 1.2, 2.4, and 4.8mM. [Ce4+] = 200µM. 
The initial rate of the reaction was calculated by using the change in absorbance (Δabs/min) and 
the molar extinction coefficient for pNPP (18.5mM
-1
cm
-1
). 
Figure 15 shows the Lineweaver-Burk plot for the same experiment. The reciprocal data seems 
to fit well linearly and strengthens the claim that cerium oxide nanoparticles follow the 
Michaelis-Menten model for enzyme kinetics. 
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Figure 15: Phosphatase activity follows Michaelis-Menten kinetics - Lineweaver-Burk plot 
Similar methodology as that for Figure 14 was adopted. 
Figure 16 shows a comparison of the phosphatase activity of 4+ and 3+ nanoparticles using the 
MUP assay which measures fluorescence. The figure clearly corroborates the data from the 
pNPP assay. The 3+ cerium oxide nanoparticles again have close to no activity. The MUP assay 
is a more sensitive assay than the pNPP assay and thus reiterates that 3+ nanoparticles are not 
catalysts when compared to 4+ nanoparticles. Figure 17 shows the result for an experiment to 
saturate the phosphatase activity in the MUP assay. The figure clearly shows that even after 2 
hours the rate of increase in intensity is linear for 4+ nanoparticles. This shows that cerium oxide 
nanoparticles can sustain their phosphatase activity over long periods of time. 
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Figure 16: 4+ nanoparticles exhibit phosphatase mimetic activity in the MUP assay 
MUP was excited at 360nm.and the change in intensity of fluorescence was measured at 449nm. 
[MUP] = 500µM and [Ce
4+
] = 200µM. 
 
Figure 17: Phosphatase activity of 4+ nanoparticles remains linear over long periods of time 
(MUP assay) 
Similar methodology as that of Figure 16 was adopted. [MUP] = 1mM and [Ce
4+
] = 200µM. 
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Figure 18 shows the result for an experiment conducted using the EnzChek® Assay on ATP. 
This graph was generated after calculating the phosphate in nmol/well from the standard curve. 
This result confirms that cerium oxide nanoparticles can act as phosphatases for bio-relevant 
substrates as well. Curve 1, 2 and 3 indicate the triplicates used in the experiment. 
 
Figure 18: 4+ nanoparticles exhibit phosphatase activity on ATP (EnzChek® assay) 
The enzymatic conversion of MESG by purine nucleoside phosphorylase into ribose 1-phosphate 
and 2-amino-6-mercapto-7-methylpurine was followed at 360nm. [ATP] = 100µM and [Ce
4+
] = 
200µM. Phosphate standard was used to calculate the nmol of phosphate/well. 
The Malachite Green assay results were not satisfactory as we had to simulate kinetic reactions 
by adding ATP at different points and then calculate the initial rate. The time points between 
readings could not be maintained precisely since the assay involved the addition of stopping 
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reagents (A and B). Even though a concurrent trend was noticed, the error in the data points was 
too large. The EnzChek® assay provided data for ATP as a substrate. 
In summary, phosphatase activity was shown by pNPP, MUP, MG and EnzChek® assays. It was 
modeled to a Michaelis-Menten profile in the pNPP assay indicating that it follows saturation 
based kinetics. 
Inhibition of Phosphatase Activity 
Three anions were identified that inhibited the phosphatase mimetic activity in a dose dependent 
manner – tungstate, molybdate and arsenate. Sulfate and selenate did not show significant 
inhibition of phosphatase activity. Figure 19 shows the Michaelis-Menten curve for the dose 
dependent inhibition of phosphatase activity using tungstate. 
 
Figure 19: Tungstate is a potent inhibitor of phosphatase activity - Michaelis-Menten curve 
Kinetic studies were performed over [pNPP] = 0.3, 0.6, 1.2, 2.4 and 4.8mM and [tungstate] = 0, 
0.15, 0.3 and 1.8mM. Rates were calculated in nmol/min using molar extinction coefficient for 
pNPP (18.5mM
-1
cm
-1
). Partial mixed inhibition was chosen as a suitable model for inhibition. 
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The figure shows a clear drop in activity as tungstate concentration (in mM) increases. At a high 
concentration of 1.8mM the activity is nearly undetectable. Figure 20 shows the Lineweaver-
Burk plot for the same experiment. The data for 1.8mM of inhibitor does not fit well with the 
trend line. This is an inherent characteristic of double reciprocal plots as the errors are magnified 
when they are inverted. Also, the actual nmol/min of phosphate being formed at 1.8mM of 
tungstate was extremely close to zero. Being so close to the detection limit explains the rather 
large error bars. 
A partial mixed inhibition model was chosen to explain tungstate inhibition. The kinetic 
parameters were as follows:- 
Vmax = 0.45nmol/min, Km = 0.77mM, Ki = 0.03mM, α = 66.14, β = 1.02 x 10
-4
.  
 
Figure 20: Tungstate is a potent inhibitor of phosphatase activity - Lineweaver-Burk plot 
Similar methodology as that for Figure 19 was adopted. 
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Figure 21 shows the Michaelis-Menten curve for the dose dependent inhibition of phosphatase 
activity using molybdate. Figure 22 shows the Lineweaver-Burk plot for the same experiment. A 
similar explanation can be provided for these figures. A partial mixed inhibition model was 
chosen to explain molybdate inhibition. The kinetic parameters were as follows:- 
 Vmax = 0.48nmol/min, Km = 1.02mM, Ki = 0.10mM, α = 4.08, β = 1.17 x 10
-2
. 
 
Figure 21: Molybdate is a potent inhibitor of phosphatase activity - Michaelis-Menten curve 
Kinetic studies were performed over [pNPP] = 0.3, 0.6, 1.2, 2.4 and 4.8mM and [molybdate] = 0, 
0.15, 0.3 and 1.8mM. Rates were calculated in nmol/min using molar extinction coefficient for 
pNPP (18.5mM
-1
cm
-1
). Partial mixed inhibition was chosen as a suitable model for inhibition. 
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Figure 22: Molybdate is a potent inhibitor of phosphatase activity - Lineweaver-Burk plot 
Similar methodology as that for Figure 21 was followed. 
Figure 23 shows the Michaelis-Menten curve for the dose dependent inhibition of phosphatase 
activity using arsenate. Figure 24 shows the Lineweaver-Burk plot for the same experiment. A 
similar explanation can be provided for these figures. A partial mixed inhibition model was 
chosen to explain arsenate inhibition. The kinetic parameters were as follows:- 
Vmax = 0.45nmol/min, Km = 0.76mM, Ki = 0.04mM, α = 6.25 x 10
5
, β = 0.55. 
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Figure 23: Arsenate is a potent inhibitor of phosphatase activity - Michaelis-Menten curve 
Kinetic studies were performed over [pNPP] = 0.3, 0.6, 1.2, 2.4 and 4.8mM and [arsenate] = 0, 
0.15, 0.3 and 1.8mM. Rates were calculated in nmol/min using molar extinction coefficient for 
pNPP (18.5mM
-1
cm
-1
). Partial mixed inhibition was chosen as a suitable model for inhibition. 
 
 
Figure 24: Arsenate is a potent inhibitor of phosphatase activity - Lineweaver-Burk plot 
Similar methodology as that for Figure 23 was adopted. 
43 
 
Inhibitory anions appear to block the active sites of the nanoparticles. Nanoparticle-Inhibitor-
Substrate complexes may have formed on the surface of the nanoparticles and led to slowing 
down of the reaction. An analog for this would be the EIS complex formed in enzyme inhibition. 
α values predict type of inhibition to be mixed while a non-zero value for β suggests that the 
inhibition is not full. Some product effectively leaks out through the conversion of EIS to E, I 
and P. This is an important consideration when trying to inhibit the activity of an enzymatic 
system. Here a distinction can be made for the β values of arsenate vs those for tungstate and 
molybdate. It is clear that tungstate and molybdate follow almost full inhibition while arsenate 
inhibition is quite weak in the sense that about 33% of the product is formed from the EIS 
complex. Table 4 summarizes the inhibition (parameters and nature) for all three anions. 
Table 4: Inhibition of phosphatase activity by anions 
Parameter Tungstate Molybdate Arsenate 
Vmax (nmol/min) 0.45 0.48 0.45 
Km (mM) 0.77 1.02 0.76 
Ki (mM) 0.03 0.10 0.04 
Α 66.14 4.08 6.25e+5 
Β 1.02e-4 1.17e-2 0.55 
Type of inhibition 
α  > > 1 
Mixed inhibition 
α  close to 1 
Mixed inhibition 
(Close to being Non-
Competitive) 
α  > > > 1 
Mixed inhibition 
Degree of inhibition 
β → 0 
Follows partial 
inhibition to a small 
extent 
β → 0 
Follows partial 
inhibition to a small 
extent 
β > 0 
Follows partial 
inhibition to a large 
extent 
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Sulfate and selenate did not show significant inhibition of the activity. Figure 25 shows the graph 
for change in absorbance at 405nm with addition of sulfate. Even after addition of 1mM of 
sulfate, there was no significant drop in the rate of the reaction. This suggests that sulfate has a 
chemistry which does not support the formation of Nanoparticle-Inhibitor-Substrate complex and 
thus it cannot inhibit the phosphatase activity. Figure 26 shows a similar graph for selenate. A 
similar inference can be drawn for selenate. 
 
Figure 25: Sulfate does not inhibit phosphatase activity 
Dose dependent inhibition of phosphatase activity was not observed by using [sulfate] = 0, 0.2, 
0.5 and 1mM. [pNPP] = 1.2mM and [Ce
4+
] = 200µM. 
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Figure 26: Selenate does not inhibit phosphatase activity 
Dose dependent inhibition of phosphatase activity was not observed by using [selenate] = 0, 0.2, 
0.5 and 1mM. [pNPP] = 1.2mM and [Ce
4+
] = 200µM. 
The MUP Assay was used to confirm the inhibition of phosphatase activity. There was a dose 
dependent decrease in intensity with increasing concentrations of arsenate (25, 50, 100 and 
200µM). 
The results for the Malachite Green assay were again unsatisfactory and hence EnzChek® assay 
results were used to confirm inhibition of phosphatase activity when ATP was the substrate. 
There was a decrease in phosphatase activity in the EnzChek® assay with addition of tungstate. 
The enzyme coupled reaction was found to be interfering results when arsenate was used. 
To summarize, the results clearly indicate that anions can form complexes on the surface of 
nanoparticles and block their active sites. This explains why their addition leads to a reduction in 
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rate of the reaction. R
2
 and AICc values for the models obtained were in favor of partial mixed 
inhibition but the degree of inhibition varied from anion to anion. 
Phosphatase Activity of Biological Phosphatase 
Calf Intestinal Phosphatase (Alkaline) was a superior phosphatase when compared to 4+ cerium 
oxide nanoparticles. CIP at a concentration of 570nM exhibited roughly the same change in 
absorbance as the cerium oxide nanoparticles that had a cerium concentration of 200µM. The 
actual concentration of the active sites of these nanoparticles was unknown. The phosphatase 
activity of CIP was also inhibited by tungstate, molybdate and arsenate. 
The results confirm that cerium oxide nanoparticles are weak phosphatases when compared to 
biological phosphatases. Their phosphatase activity however, can be used as a model catalytic 
activity and can provide information on bioavailability and toxicity. 
Oxidation State of Cerium Oxide Nanoparticles 
The results from XPS data with and without inhibitors are shown below. The values for Binding 
Energy of electrons of cerium atoms are plotted against intensity of signal. Figures 27-30 show 
the results for XPS analysis on 4+ cerium oxide nanoparticles with and without inhibitors 
(tungstate, molybdate and arsenate). Figures 31-34 show the results for XPS analysis on 3+ 
cerium oxide nanoparticles with and without inhibitors (tungstate, molybdate and arsenate). The 
figures were compared to notice any obvious deviations in peaks. The 917nm peak (representing 
Ce
4+
) decreased in area as the concentration of Ce
3+
 increased.
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Figure 27: Binding energy spectrum for 3d orbital of Ce
4+
 nanoparticles 
Nanoparticle solution with Ce
4+
 at 5mM was repeatedly applied to a silicon wafer and allowed to dry till a visible layer was 
noticeable. The binding energy spectrum for the 3d orbital of cerium was then generated using XPS. 
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Figure 28: Tungstate does not significantly alter the binding energy spectrum for 4+ nanoparticles 
Similar methodology as that for Figure 27 was adopted. Equimolar concentration of tungstate was mixed with nanoparticle solution 
and applied to a silicon wafer. 
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Figure 29: Molybdate does not significantly alter the binding energy spectrum for 4+ nanoparticles 
Similar methodology as that for Figure 27 was adopted. Equimolar concentration of molybdate was mixed with nanoparticle solution 
and applied to a silicon wafer. 
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Figure 30: Arsenate significantly alters the binding energy spectrum for 4+ nanoparticles 
Similar methodology as that for Figure 27 was adopted. Equimolar concentration of arsenate was mixed with nanoparticle solution 
and applied to a silicon wafer. 
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Figure 31: Binding energy spectrum for 3d orbital of Ce
3+
 nanoparticles 
Similar methodology as that for Figure 27 was adopted. 
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Figure 32: Tungstate significantly alters the binding energy spectrum for 3+ nanoparticles 
Similar methodology as that for Figure 27 was adopted. Equimolar concentration of tungstate was mixed with nanoparticle solution 
and applied to a silicon wafer. 
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Figure 33: Molybdate does not significantly alter the binding energy spectrum for 3+ nanoparticles 
Similar methodology as that for Figure 27 was adopted. Equimolar concentration of molybdate was mixed with nanoparticle solution 
and applied to a silicon wafer. 
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Figure 34: Arsenate significantly alters the binding energy spectrum for 3+ nanoparticles 
Similar methodology as that for Figure 27 was adopted. Equimolar concentration of arsenate was mixed with nanoparticle solution 
and applied to a silicon wafer. 
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Table 5 lists the concentration of cerium atoms in the 3+ state on the nanoparticle samples that 
were used in the XPS experiments. 
Table 5: Concentration of Ce
3+
 in nanoceria samples with and without inhibitors 
 
Concentration of Ce
3+
 in sample (%) 
Control Tungstate Molybdate Arsenate 
P
re
d
o
m
in
an
t 
st
at
e 3+ 59.5 48.0 58.1 63.6 
4+ 24.9 25.2 23.0 21.4 
Ce
3+
 concentration changed significantly in the presence of arsenate for both 3+ and 4+ 
nanoparticles. The values for other inhibitors remained roughly the same except for tungstate 
with 3+ nanoparticles. These results suggest that for the purposes of studying phosphatase 
activity there is no significant change in the state of 4+ cerium oxide nanoparticles when exposed 
to inhibitors. Spectra for binding energy of cerium electrons in the 3d orbital with j values of 5/2 
and 3/2 were used a comparison to ensure that the results obtained were not anomalous. 
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CONCLUSION 
The goal of this project was to study the phosphatase activity of cerium oxide nanoparticles and 
find ways of controlling it. Cerium atoms that are in the 4+ state allow the hydrolytic cleavage of 
phosphate anion from donor substrates. Those in the 3+ state do not show this activity. This was 
confirmed by absorbance, for pNPP and ATP and by fluorescence for an alternate substrate, 
MUP. Water was found to play an essential role in the catalytic reaction – based on reactions 
using either pNPP or MUP. Their phosphatase activity is weak when compared to biological 
phosphatases. 
Anions that are similar in structure to phosphate are able to inhibit the phosphatase mimetic 
activity in a dose dependent manner. Tungstate, molybdate and arsenate inhibition data were fit 
to a partial mixed inhibition model. It is likely that all three anions were efficient in binding to 
the cerium oxide nanoparticles and blocking reactive sites that would have otherwise been 
occupied by phosphate anions. The fact that they fit a mixed model of inhibition implies that the 
inhibitors can bind to both the nanoparticles and a nanoparticle-phosphate complex with varying 
affinities. Since there is no reason to doubt that a nanoparticle-phosphate-inhibitor complex can 
also lead to free phosphate, the model makes most sense when classified as partial mixed 
inhibition. On the whole, tungstate and molybdate seem to follow an inhibition model that is 
almost full (β → 0) while arsenate inhibition is essentially leaky (β > 0). Molybdate inhibition is 
quite close to a special case of mixed inhibition when α = 1 (Non-competitive Inhibition) while 
the values of α for tungstate and arsenate are well above 0. 
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Since cerium oxide nanoparticles are established scavengers of reactive oxygen and nitrogen 
species, it is useful to study other catalytic activities (such as phosphatase activity) that will 
qualify their biomedical applications by rendering information on parameters such as 
bioavailability and toxicity. We have used phosphatase activity as a model catalytic activity 
because it is easy to follow and the trend for 4+ cerium oxide nanoparticles can be quickly 
correlated to catalase activity.  
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APPENDIX 
COPYRIGHT PERMISSION LETTER 
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The following is a notice of confirmation for permission to use Figure 4.
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